| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |